Insider Cluster (2 insiders) ·Filed Aug 18, 2026

ELAN

Elanco Animal Health Inc
BULLISH
Impact 4/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $203K total
Actionable Insight ▲ Bullish

The insider buys are a modest bullish signal reinforcing the post-earnings positive read. Monitor for further C-suite open-market purchases — if more top executives buy in the next 2-4 weeks, it would confirm strong conviction behind the raised guidance.

DirectionBullish
Confidencehigh
Horizondays
Latest settled — T+20d
ELAN ▼ -3.25% at T+20d
LONG call ✗ call lost -3.25% · α vs SPY -1.94% · entry $23.63 → $22.86
Next anchor: T+60d in 6w
Latest observation: T+30 -1.44% FF3 residual α
Entry anchored
Aug 17, 05:21 PM ET
via 1-min bar
T+1d
+3.64%
call +3.64% · α +3.43%
$24.49
settled 6w ago
T+5d
+6.19%
call +6.19% · α +6.39%
$25.09
settled 6w ago
T+20d
-3.25%
call -3.25% · α -1.94%
$22.86
settled 17d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Two ELAN insiders—Director Michael J. Harrington and General Counsel Shiv O'Neill—made open-market purchases totaling $203K over a one-week window ending August 18, 2026, following the company's Q2 2026 beat-and-raise earnings report. Harrington bought 5,000 shares at $21.82 on August 12, and O'Neill bought 3,998 shares at $23.58 on August 18. The buying supports the bullish earnings narrative but is small relative to Elanco's $11.8B market cap ($203K = ~0.002%), making it a modest confidence signal rather than a market-moving event. The cluster of buys—especially after a positive earnings catalyst—is directionally consistent with management's confidence in the raised guidance.

Key Financial Metrics

Direction
buying
Total Value
$203.4K
Insiders
2

Key Facts

  • Insider cluster of two open-market purchases totaling $203,273 — 0.002% of market cap.
  • Director Michael J. Harrington bought 5,000 shares at $21.82 ($109,100) on August 12, 2026.
  • GC & Corp Sec Shiv O'Neill bought 3,998 shares at $23.58 ($94,273) on August 18, 2026.
  • Buys come 7-14 days after a bullish Q2 2026 earnings beat (adj. EPS $0.34 vs. $0.27 consensus) and raised FY guidance.
  • No 10b5-1 pattern evident — timing and sizes suggest opportunistic conviction buying.

Financial Impact

Insider purchases total ~0.002% of $11.8B market cap — economically trivial but directionally positive as a signal.

Risk Factors

  • Dollar amount is negligible relative to market cap — should not be overweighted.
  • Single C-suite buyer (GC, not CEO/CFO) limits signal strength.
  • ELAN is highly followed (91% analyst bullish) — upside may be priced in already.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (23 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ELAN-1787121145985
13 reports for ELAN
Performance horizon
75% Hit rate 6 of 8 directional calls best @ T+5▲ +15.03%May 19, 2026
Filters
Rows
Reports for ELAN — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Press Release
BULLISH ★ 6/10
$23.17 $22.42▼ −3.24%▼ −3.02%$22.14 (−4.45%)
Aug 21, 2026
6w ago
Insider Cluster
BULLISH ★ 6/10
$23.97 $24.11▲ +0.58%▲ +0.11%$22.14 (−7.63%)
Aug 21, 2026
6w ago
Insider Cluster
BULLISH ★ 4/10
$23.97 $24.11▲ +0.58%▲ +0.11%$22.14 (−7.63%)
Aug 18, 2026
6w ago
Insider Cluster
BULLISH ★ 4/10
$23.63 $25.09▲ +6.19%▲ +6.39%$22.14 (−6.30%)
Aug 13, 2026
7w ago
Insider Cluster
BULLISH ★ 4/10
$22.51 $23.56▲ +4.66%▲ +6.63%$22.14 (−1.64%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$22.73 $23.64▲ +4.00%▲ +4.41%$22.14 (−2.60%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$26.22 $22.04▼ −15.95%▼ −16.30%$22.14 (−15.56%)
Jun 29, 2026
13w ago
Court Ruling
NEUTRAL ★ 2/10
$24.74 $25.13▲ +1.58%▲ +0.19%$22.14 (−10.51%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$23.61 $24.58▲ +4.11%▲ +3.64%$22.14 (−6.22%)
May 19, 2026
19w ago
Insider Cluster
BULLISH ★ 4/10
$20.83 $23.69▲ +13.74%▲ +12.50%$22.14 (+6.30%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (64h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 19, 2026